Jiandie Lin, a research and developmental biology professor at the U-M Life Sciences Institute, discusses research finding that a hormone derived from fat cells can restrain the growth of liver tumors in mice, helping create therapies to combat liver cancer, specifically hepatocellular carcinoma. Lin notes details from the study using mice to monitor molecular and cellular changes amplified by nonalcoholic fatty liver disease and how those changes lead to this disease. The faculty expert highlights how their research focuses on a fat-derived hormone to reprogram the liver environment rather than focusing on a liver-centered framework.
Free Stadium Blanket. Join for Life.